ZA9711207B - Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azahetero-cyclylamide compounds - Google Patents
Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azahetero-cyclylamide compoundsInfo
- Publication number
- ZA9711207B ZA9711207B ZA9711207A ZA9711207A ZA9711207B ZA 9711207 B ZA9711207 B ZA 9711207B ZA 9711207 A ZA9711207 A ZA 9711207A ZA 9711207 A ZA9711207 A ZA 9711207A ZA 9711207 B ZA9711207 B ZA 9711207B
- Authority
- ZA
- South Africa
- Prior art keywords
- cyclylamide
- azahetero
- sulfonylamino
- heteroaralkyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3315996P | 1996-12-13 | 1996-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9711207B true ZA9711207B (en) | 1998-07-20 |
Family
ID=21868858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9711207A ZA9711207B (en) | 1996-12-13 | 1997-12-12 | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azahetero-cyclylamide compounds |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0944386B1 (pt) |
| JP (1) | JP4223560B2 (pt) |
| KR (1) | KR20000057528A (pt) |
| CN (1) | CN1244798A (pt) |
| AP (1) | AP1032A (pt) |
| AT (1) | ATE224192T1 (pt) |
| AU (1) | AU726637B2 (pt) |
| BG (1) | BG103558A (pt) |
| BR (1) | BR9713921A (pt) |
| CA (1) | CA2274686C (pt) |
| DE (1) | DE69715658T2 (pt) |
| DK (1) | DK0944386T3 (pt) |
| EA (1) | EA002817B1 (pt) |
| ES (1) | ES2184145T3 (pt) |
| HU (1) | HUP9904188A3 (pt) |
| IL (1) | IL130152A0 (pt) |
| NO (1) | NO312416B1 (pt) |
| OA (1) | OA11062A (pt) |
| PL (1) | PL333921A1 (pt) |
| PT (1) | PT944386E (pt) |
| SK (1) | SK71299A3 (pt) |
| WO (1) | WO1998025611A1 (pt) |
| ZA (1) | ZA9711207B (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6602864B1 (en) * | 1996-12-13 | 2003-08-05 | Aventis Pharma Deutschland Gmbh | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds |
| US6281227B1 (en) * | 1996-12-13 | 2001-08-28 | Aventis Pharma Deutschland Gmbh | Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| IL123986A (en) * | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
| AR016817A1 (es) * | 1997-08-14 | 2001-08-01 | Smithkline Beecham Plc | Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento |
| AU8875798A (en) | 1997-08-29 | 1999-03-22 | Proteus Molecular Design Ltd | Meta-benzamidine derivatives as serin protease inhibitors |
| ES2255733T3 (es) * | 1997-09-30 | 2006-07-01 | Daiichi Pharmaceutical Co., Ltd. | Derivados sulfonilo. |
| CA2324153A1 (en) | 1998-03-19 | 1999-09-23 | Ajinomoto Co., Inc. | Aminoisoquinoline derivatives |
| CA2340100A1 (en) * | 1998-08-11 | 2000-02-24 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
| US7229986B2 (en) * | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
| GB0114004D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| GB0114005D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| GB0127568D0 (en) | 2001-11-16 | 2002-01-09 | Glaxo Group Ltd | Chemical compounds |
| WO2003106445A1 (en) * | 2002-06-12 | 2003-12-24 | Qsi Pharma A/S | Compounds and methods for controlling bacterial virulence |
| HUE025683T2 (hu) | 2002-12-03 | 2016-04-28 | Pharmacyclics Llc | VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok |
| US20070161627A1 (en) * | 2004-08-09 | 2007-07-12 | Miller William H | Antibacterial agents |
| FR2890072A1 (fr) | 2005-09-01 | 2007-03-02 | Fournier S A Sa Lab | Nouveaux composesde pyrrolopyridine |
| WO2007029629A1 (ja) * | 2005-09-06 | 2007-03-15 | Shionogi & Co., Ltd. | Ｐｇｄ２受容体アンタゴニスト活性を有するインドールカルボン酸誘導体 |
| FR2955110A1 (fr) | 2010-01-08 | 2011-07-15 | Fournier Lab Sa | Nouveaux derives de type pyrrolopyridine benzoique |
| EP2606893A1 (en) | 2011-12-21 | 2013-06-26 | Sanofi | Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application |
| CN104098497B (zh) * | 2014-06-17 | 2016-04-13 | 王庚禹 | 一种新的酰胺类化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4121947A1 (de) * | 1991-07-03 | 1993-01-07 | Basf Ag | 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung |
| WO1995035311A1 (en) * | 1994-06-17 | 1995-12-28 | Corvas International, Inc. | 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors |
| US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
-
1997
- 1997-12-03 EP EP97951573A patent/EP0944386B1/en not_active Expired - Lifetime
- 1997-12-03 CN CN97181387A patent/CN1244798A/zh active Pending
- 1997-12-03 KR KR1019990705236A patent/KR20000057528A/ko not_active Application Discontinuation
- 1997-12-03 BR BR9713921A patent/BR9713921A/pt not_active IP Right Cessation
- 1997-12-03 EA EA199900542A patent/EA002817B1/ru not_active IP Right Cessation
- 1997-12-03 HU HU9904188A patent/HUP9904188A3/hu unknown
- 1997-12-03 AP APAP/P/1999/001552A patent/AP1032A/en active
- 1997-12-03 SK SK712-99A patent/SK71299A3/sk unknown
- 1997-12-03 PL PL97333921A patent/PL333921A1/xx unknown
- 1997-12-03 WO PCT/US1997/022406 patent/WO1998025611A1/en not_active Application Discontinuation
- 1997-12-03 DK DK97951573T patent/DK0944386T3/da active
- 1997-12-03 AT AT97951573T patent/ATE224192T1/de not_active IP Right Cessation
- 1997-12-03 CA CA002274686A patent/CA2274686C/en not_active Expired - Fee Related
- 1997-12-03 PT PT97951573T patent/PT944386E/pt unknown
- 1997-12-03 JP JP52684498A patent/JP4223560B2/ja not_active Expired - Fee Related
- 1997-12-03 AU AU55182/98A patent/AU726637B2/en not_active Ceased
- 1997-12-03 DE DE69715658T patent/DE69715658T2/de not_active Expired - Lifetime
- 1997-12-03 IL IL13015297A patent/IL130152A0/xx unknown
- 1997-12-03 ES ES97951573T patent/ES2184145T3/es not_active Expired - Lifetime
- 1997-12-12 ZA ZA9711207A patent/ZA9711207B/xx unknown
-
1999
- 1999-06-11 NO NO19992853A patent/NO312416B1/no unknown
- 1999-06-11 OA OA9900124A patent/OA11062A/en unknown
- 1999-07-07 BG BG103558A patent/BG103558A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0944386A4 (en) | 2001-04-11 |
| ES2184145T3 (es) | 2003-04-01 |
| DE69715658D1 (de) | 2002-10-24 |
| ATE224192T1 (de) | 2002-10-15 |
| NO992853L (no) | 1999-08-10 |
| EA199900542A1 (ru) | 2000-02-28 |
| BR9713921A (pt) | 2000-03-21 |
| EP0944386A1 (en) | 1999-09-29 |
| JP4223560B2 (ja) | 2009-02-12 |
| OA11062A (en) | 2002-03-11 |
| JP2001506630A (ja) | 2001-05-22 |
| CA2274686A1 (en) | 1998-06-18 |
| DE69715658T2 (de) | 2003-05-22 |
| AP9901552A0 (en) | 1999-06-30 |
| NO992853D0 (no) | 1999-06-11 |
| WO1998025611A1 (en) | 1998-06-18 |
| EA002817B1 (ru) | 2002-10-31 |
| BG103558A (en) | 2000-04-28 |
| KR20000057528A (ko) | 2000-09-25 |
| EP0944386B1 (en) | 2002-09-18 |
| AU5518298A (en) | 1998-07-03 |
| PT944386E (pt) | 2003-01-31 |
| DK0944386T3 (da) | 2003-01-27 |
| AP1032A (en) | 2001-12-24 |
| HUP9904188A3 (en) | 2003-02-28 |
| NO312416B1 (no) | 2002-05-06 |
| CA2274686C (en) | 2009-02-03 |
| AU726637B2 (en) | 2000-11-16 |
| SK71299A3 (en) | 2000-12-11 |
| PL333921A1 (en) | 2000-01-31 |
| CN1244798A (zh) | 2000-02-16 |
| HUP9904188A1 (hu) | 2000-06-28 |
| IL130152A0 (en) | 2000-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9904188A3 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| AU1704201A (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| GB9626637D0 (en) | Percarboxyilic acid solutions | |
| AP9901504A0 (en) | Bicyclic hydroxamic acid derivatives | |
| HUP0002960A3 (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
| EP0777672A4 (en) | AMINO ACID COMPLEXES WITH IMPROVED TASTE | |
| GB9307956D0 (en) | Hydroxamic acid derivatives | |
| EP0894088A4 (en) | SUBSTITUTED COMPOUNDS BASED ON N- (AMINOIMINOMETHYL) PHENYLALKYL] -AZAHETEROCYCLYLAMIDE SULFONIC ACID | |
| NO991561L (no) | 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser | |
| AU5345798A (en) | Fructan-polycarboxylic acid | |
| ZA9510888B (en) | 3-aryl-tetronic acid derivatives | |
| IL129166A0 (en) | Hydroxamic acid derivatives | |
| GB9910935D0 (en) | Amino acid sequence | |
| AU5319898A (en) | Glyoxylic acid amides | |
| KR0137670B1 (en) | 5-METHYL-5-0-(Ñß-D-GLUCOPYRANOSYL)-D-ERYTHROASCORBIC ACID | |
| GB9408183D0 (en) | Hydroxamic acid derivatives | |
| HU9401969D0 (en) | Hydroxamic acid derivatives | |
| ZA978800B (en) | Hydroxamic acid derivatives. | |
| KR0137624B1 (en) | 5-METHYL-5-0(Ñß-D-ZYLOPYRANOSYL)-D-ERYTHROASCORBIC ACID | |
| SI1003720T1 (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
| SI0934286T1 (en) | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | |
| IL108591A0 (en) | Amino acid sequence determination | |
| GR1002102B (en) | Mixture of inorganic salts which prevents the sulfation of the lead-sulfuric acid batteries. | |
| AU5490898A (en) | Amino acid compounds | |
| ZA9711559B (en) | Amino butyric acid fungicides. |